KYLE TISI: Open Payments
NPI 1366813602 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 47 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $149 · 2025 $961
Food & beverage: $658Education: $303
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $266 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $164 |
| GENZYME CORPORATION | 6 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Organon LLC | 4 | $39 |
| LEO Pharma Inc. | 1 | $27 |
| KYOWA KIRIN, INC. | 1 | $24 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: DUPIXENT, COSENTYX, ILUMYA, ANZUPGO, POTELIGEO, JUBLIA, LIBTAYO, NEMLUVIO.
Industry payments across AZ — which companies pay providers there.
